Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 in the footer, and Revision: v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-15T03:44:36.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Locations section added with state-level site listings (Florida, Georgia, Indiana, Kansas, Louisiana, Missouri, New York, North Carolina, Rhode Island, South Carolina, Texas, Utah). Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure element.
    Difference
    1%
    Check dated 2025-12-24T14:34:41.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Minor editorial updates: the Publications disclaimer was reworded from 'study results' to 'results of the study', and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:45:43.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The government funding status banner warning about potential delays and operating status has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T17:23:35.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The latest view shows minor layout refinements and reformatting of sections, with no changes to the study title, description, eligibility criteria, primary/secondary outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T09:56:42.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    The page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T14:29:43.000Z thumbnail image

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.